2K. A. Jellinger. Cell death mechanisms in Parkinson’s disease[J] 2000,Journal of Neural Transmission(1):1～29 被引量：1
二级参考文献9
1Kannan R, Unhltenhamp JF, Tamldidier E. Evidence for carrier-mediated transport of glutathione across the blood brain barrier in the rat [J].Journal of Clinical Investigation, 1990,85:2009-2013. 被引量：1
2Sechi G, Deeden MG, Bua G. Reduced intraveneous glutathione in the treatment of early Parkinsons disease [J].Progress in Neumiasychophannacology and biological psychiatry, 1996,20:1159-1170. 被引量：1
3Fahn S, Gohen G. The oxidam stress hypothesis in Parkinson' s disease:evidence supporting it[J]. Ann Neurol. 1992,32:804-812. 被引量：1
4Burch D,Sheerin F. Parkinson's disease[J].{H}LANCET,2005,(9459):622-627. 被引量：1
5Abdulwahid Arif I,Ahmad Khan H. Environmental toxins and Parkinson's disease:putative roles of impaired electron transport chain and oxidative stress[J].{H}Toxicology and Industrial Health,2010,(02):121-128. 被引量：1
6Cookson MR. The biochemistry of Parkinson's disease[J].Ann Rev Biochem,2005.29-52. 被引量：1
7Kostrzewa RM,Kostrzewa JP,Brus R. Neuroprotective and neurotoxic roles of levodopa(L-DOPA) in neurodegenerative disorders relating to Parkinson's disease[J].{H}AMINO ACIDS,2002,(1-3):57-63. 被引量：1
8Fonck C,Baudry M. Rapid reduction of ATP synthesis and lack of free radical formation by MPP + in rat brain synaptosomes and mitochondria[J].{H}Brain Research,2003,(1-2):214-221. 被引量：1
9Watanabe H,Muramatsu Y,Kumsaki R. Protective effects of neuronal nitric oxide synthase inhibitor in mouse brain against MPTP neurotoxicity:an immunohistological study[J].{H}European Neuropsychopharmacology,2004,(02):93-104. 被引量：1
10Laederach A,Shcherbakova I,Jonikas MA. Distinc contribution of electrostatics,initial conformational ensemble,and macromolecular stability in RNA folding[J].{H}Proceedings of the National Academy of Sciences(USA),2007,(17):7045-7050. 被引量：1
